{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:50:54Z","timestamp":1782978654391,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K09050"],"award-info":[{"award-number":["17K09050"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jphs.2019.07.011","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T13:43:45Z","timestamp":1564494225000},"page":"255-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of geldanamycin on neurite outgrowth-related proteins and kinases in nerve growth factor-differentiated pheochromocytoma 12\u00a0cells"],"prefix":"10.1016","volume":"140","author":[{"given":"Keisuke","family":"Migita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jphs.2019.07.011_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.canlet.2010.10.014","article-title":"Targeting heat shock proteins in cancer","volume":"332","author":"Jego","year":"2013","journal-title":"Cancer Lett"},{"issue":"9","key":"10.1016\/j.jphs.2019.07.011_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/bjc.2017.302","article-title":"A\u00a0phase I\/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed\/refractory multiple myeloma","volume":"117","author":"Cavenagh","year":"2017","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.jphs.2019.07.011_bib3","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3109\/10428194.2015.1129536","article-title":"A\u00a0phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"57","author":"Maddocks","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.jphs.2019.07.011_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00280-016-3102-y","article-title":"A\u00a0phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer","volume":"78","author":"Renouf","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.jphs.2019.07.011_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/bjc.2015.422","article-title":"Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies","volume":"114","author":"Yong","year":"2016","journal-title":"Br J Cancer"},{"issue":"1\u20132","key":"10.1016\/j.jphs.2019.07.011_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-5793(01)02130-5","article-title":"Opposite effects of the Hsp90 inhibitor Geldanamycin: induction of apoptosis in PC12, and differentiation in N2A cells","volume":"490","author":"Lopez-Maderuelo","year":"2001","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.jphs.2019.07.011_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)80203-2","article-title":"Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent","volume":"89","author":"Stebbins","year":"1997","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jphs.2019.07.011_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"20","key":"10.1016\/j.jphs.2019.07.011_bib9","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1073\/pnas.170276797","article-title":"Modulation of Akt kinase activity by binding to Hsp90","volume":"97","author":"Sato","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"10.1016\/j.jphs.2019.07.011_bib10","doi-asserted-by":"crossref","first-page":"39858","DOI":"10.1074\/jbc.M206322200","article-title":"Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function","volume":"277","author":"Basso","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.jphs.2019.07.011_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093223","article-title":"Inhibition of nerve growth factor-induced neurite outgrowth from PC12 cells by dexamethasone: signaling pathways through the glucocorticoid receptor and phosphorylated Akt and ERK1\/2","volume":"9","author":"Terada","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2019.07.011_bib12","first-page":"23","article-title":"Modulation of neurotrophic signaling pathways by polyphenols","volume":"10","author":"Moosavi","year":"2016","journal-title":"Drug Des Dev Ther"},{"issue":"3","key":"10.1016\/j.jphs.2019.07.011_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1016-8478(23)13124-4","article-title":"A\u00a0positive role of the PI3-K\/Akt signaling pathway in PC12 cell differentiation","volume":"18","author":"Kim","year":"2004","journal-title":"Mol Cells"},{"key":"10.1016\/j.jphs.2019.07.011_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1741-7007-12-47","article-title":"Neuronal deletion of GSK3beta increases microtubule speed in the growth cone and enhances axon regeneration via CRMP-2 and independently of MAP1B and CLASP2","volume":"12","author":"Liz","year":"2014","journal-title":"BMC Biol"},{"issue":"1","key":"10.1016\/j.jphs.2019.07.011_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cell.2004.11.012","article-title":"GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity","volume":"120","author":"Yoshimura","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jphs.2019.07.011_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnmol.2012.00003","article-title":"Coordinating gene expression and axon assembly to control axon growth: potential role of GSK3 signaling","volume":"5","author":"Liu","year":"2012","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"10.1016\/j.jphs.2019.07.011_bib17","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/sj.emboj.7600237","article-title":"A\u00a0novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons","volume":"23","author":"Morfini","year":"2004","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.jphs.2019.07.011_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0962-8924(01)02181-X","article-title":"Cdk5 behind the wheel: a role in trafficking and transport?","volume":"12","author":"Smith","year":"2002","journal-title":"Trends Cell Biol"},{"issue":"4\u20135","key":"10.1016\/j.jphs.2019.07.011_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000074626","article-title":"Cdk5 in neuroskeletal dynamics","volume":"12","author":"Smith","year":"2003","journal-title":"Neurosignals"},{"issue":"3","key":"10.1016\/j.jphs.2019.07.011_bib20","first-page":"797","article-title":"Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90","volume":"29","author":"Koga","year":"2009","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.jphs.2019.07.011_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/WNR.0b013e32833a7d53","article-title":"Role of collapsin response mediator protein-2 in neurite outgrowth of PC12 cells","volume":"21","author":"Bork","year":"2010","journal-title":"Neuroreport"},{"issue":"41","key":"10.1016\/j.jphs.2019.07.011_bib22","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.1523\/JNEUROSCI.3184-04.2004","article-title":"Alpha2-chimaerin, cyclin-dependent Kinase 5\/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse","volume":"24","author":"Brown","year":"2004","journal-title":"J\u00a0Neurosci"},{"issue":"26","key":"10.1016\/j.jphs.2019.07.011_bib23","doi-asserted-by":"crossref","first-page":"18227","DOI":"10.1074\/jbc.M801645200","article-title":"Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation","volume":"283","author":"Cole","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.jphs.2019.07.011_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091978","article-title":"Targeting heat shock proteins in cancer: a promising therapeutic approach","volume":"18","author":"Chatterjee","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jphs.2019.07.011_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/pri.1.1.4059","article-title":"Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27","volume":"1","author":"Lanneau","year":"2007","journal-title":"Prion"},{"issue":"10","key":"10.1016\/j.jphs.2019.07.011_bib26","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.freeradbiomed.2009.08.012","article-title":"Role of oxidative stress in geldanamycin-induced cytotoxicity and disruption of Hsp90 signaling complex","volume":"47","author":"Clark","year":"2009","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.jphs.2019.07.011_bib27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2131\/jts.37.1049","article-title":"Effects of Hsp90 inhibitors, geldanamycin and its analog, on ceramide metabolism and cytotoxicity in PC12 cells","volume":"37","author":"Toyomura","year":"2012","journal-title":"J\u00a0Toxicol Sci"},{"issue":"5573","key":"10.1016\/j.jphs.2019.07.011_bib28","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1126\/science.1071552","article-title":"Signaling pathways for PC12 cell differentiation: making the right connections","volume":"296","author":"Vaudry","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jphs.2019.07.011_bib29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.neuroscience.2007.03.001","article-title":"Induction of neurite outgrowth in PC12 cells by the medium-chain fatty acid octanoic acid","volume":"146","author":"Kamata","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.jphs.2019.07.011_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2013.05.015","article-title":"Partial rescue of geldanamycin-induced TrkA depletion by a proteasome inhibitor in PC12 cells","volume":"1520","author":"Berta","year":"2013","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.jphs.2019.07.011_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1471-4159.2004.02350.x","article-title":"Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival","volume":"89","author":"Zheng","year":"2004","journal-title":"J\u00a0Neurochem"},{"issue":"5","key":"10.1016\/j.jphs.2019.07.011_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1586\/14737140.8.5.757","article-title":"AKT pathway in neuroblastoma and its therapeutic implication","volume":"8","author":"Sartelet","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.jphs.2019.07.011_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.abb.2013.04.015","article-title":"Phosphorylation accelerates geldanamycin-induced Akt degradation","volume":"536","author":"Su","year":"2013","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.jphs.2019.07.011_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2005.11.147","article-title":"Ras regulates neuronal polarity via the PI3-kinase\/Akt\/GSK-3beta\/CRMP-2 pathway","volume":"340","author":"Yoshimura","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"22","key":"10.1016\/j.jphs.2019.07.011_bib35","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1128\/MCB.25.22.9920-9935.2005","article-title":"CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1\/WAVE1 complex and axon formation","volume":"25","author":"Kawano","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"38","key":"10.1016\/j.jphs.2019.07.011_bib36","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1523\/JNEUROSCI.3120-11.2011","article-title":"Cdk5-mediated phosphorylation of Axin directs axon formation during cerebral cortex development","volume":"31","author":"Fang","year":"2011","journal-title":"J\u00a0Neurosci"},{"issue":"5","key":"10.1016\/j.jphs.2019.07.011_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.devcel.2009.03.005","article-title":"Anterograde transport of TrkB in axons is mediated by direct interaction with Slp1 and Rab27","volume":"16","author":"Arimura","year":"2009","journal-title":"Dev Cell"},{"issue":"10","key":"10.1016\/j.jphs.2019.07.011_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.tibs.2015.08.003","article-title":"Regulation of axonal transport by protein kinases","volume":"40","author":"Gibbs","year":"2015","journal-title":"Trends Biochem Sci"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861319356919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861319356919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:58:52Z","timestamp":1761163132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861319356919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1347861319356919"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2019.07.011","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of geldanamycin on neurite outgrowth-related proteins and kinases in nerve growth factor-differentiated pheochromocytoma 12\u00a0cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2019.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}